USPTO serial 79244443
BRIGHTER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, YATSYE ISADORA
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BRIGHTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
REBECCA B LEDERHOUSE
REBECCA B LEDERHOUSE BAKER & MCKENZIE LLP300 EAST RANDOLPH ST STE 5000CHICAGO, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | portable first-aid kits; reagents for blood grouping for medical purposes; diagnostic agents for pharmaceutical use; diagnostic reagents for medical use; chemical preparations for the diagnosis of diabetes; chemical preparations for testing blood for medical purposes; test strips for measuring blood glucose levels; antibodies for use in disease testing; blood tonics for medical purposes; starch for dietetic or pharmaceutical purposes; aseptic cotton; cotton for medical purposes; glucose dietary supplements | ABANDONED | — |
| 009 | Dosimeters; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication; liquid dosage devices that measure the amounts to be dispensed; vials for laboratory use; vials for scientific purposes; instruments for diagnosis for scientific use, namely, diagnostic apparatus for the detection, monitoring and treatment of chronic medical conditions; network access server hardware; downloadable computer application software for the detection, monitoring and treatment of chronic medical conditions; measuring, detecting and monitoring instruments, indicators and controllers for detection, monitoring and treatment of chronic medical conditions; downloadable computer software programs for the detection, monitoring and treatment of chronic medical conditions; downloadable computer software for the detection, monitoring and treatment of chronic medical conditions; data recorded electronically in the field of chronic medical conditions; downloadable graphics for mobile phones; downloadable computer software for data processing in the field of medical support; downloadable computer software programs for monitoring medical computer application software for mobile phones in the field of chronic medical conditions; data processing apparatus; central processing units for processing information, data, sound or images; real-time data processing apparatus | ABANDONED | — |
| 010 | Medical test kits for diabetes monitoring for home use; meters for measuring blood glucose; blood glucose testing apparatus for medical purposes; blood glucose monitoring apparatus for medical purposes; automatic medical apparatus for dosing humans by injection; pumps for medical use in dispensing pharmaceuticals from containers; medical apparatus for testing the level of glucose in the blood; blood testing apparatus; apparatus for taking blood; apparatus for blood tests for medical use; pharmaceutical instruments for injecting medication; meters for body fluids for medical purposes; suture needles; acupuncture needles; needles for medical purposes; arterial blood pressure measuring apparatus; digital electronic sphygmomanometers; apparatus for blood analysis for medical use; disposable lancets for finger puncture; disposable needles for hypodermic syringes; disposable syringes; injection device for pharmaceuticals; injection needles for medical use; syringes for injections; applicators for medications; medical apparatus for introducing pharmaceutical preparations into the human body; medical hand tools, namely, blood testers for diabetes care; shields for medical instruments; apparatus for blood analysis for medical use; apparatus for blood monitoring for medical use; diabetes diagnostic apparatus for medical purposes; electric instruments for medical use in the diagnosis of blood | ABANDONED | — |
| 035 | compilation and systemization of information into computer databases; computerized file management; compilation of data into computer databases; systemization of information into computer databases; compiling of information into computer databases; collection and systematization of information into computer databases; processing of data; data entry and processing of data; data processing; compilation of data into computer databases; none of the above to include health care provider referral services nor appointment scheduling services nor billing services nor statistical evaluation of insurance claims nor record keeping services for risk management nor regulatory compliance | ABANDONED | — |
| 038 | Transmission of information relating to pharmaceuticals, medicine and hygiene; distribution of data or audio visual images via a global computer network or the internet; electronic transmission of data and documents via computer terminals; electronic transmission of data and documents via computer terminals and electronic devices; electronic exchange of data stored in databases accessible via telecommunication networks; electronic message transmission services; international data transmission; transmission of data by electronic means; transmission of data by audio-visual apparatus; transmission of information on-line; transmission of digital files; services for the electronic transmission of information via telecommunication systems and data communication systems; provision of access to databases via the internet; providing online access to medical data from a database or from the internet; none of the above to include rankings, ratings, reviews, referrals or recommendations relating to health care providers | ABANDONED | — |
| 042 | Medical research; pharmaceutical research services; blood analysis services; drug discovery services; inspection of pharmaceuticals; research on the subject of pharmaceuticals; pharmaceutical drug development services; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of computer databases; design of software; computer software research; software creation; professional advisory services relating to computer software; computer software consultancy; medical and pharmacological research services; research services in the field of natural science; pharmaceutical research and development; development of pharmaceutical preparations and medicines; laboratory testing of materials; research and development of new products; product research and development; technical research in the field of medicine; advisory services relating to the design and development of scientific instruments; advisory services relating to scientific research; advisory services relating to technological research; preparation of reports relating to scientific research; development of new technology for others in the field of medicine; development of new products; scientific services, namely, engineering and research relating to new product development; providing science technology information; testing, authentication and quality control in the field of medical devices; development of computer software application solutions; development of computer software; scientific computer programming services; development of systems for the processing of data; cloud computing services featuring software for the diagnosis and treatment of medical conditions; software as a service (SaaS) featuring software for the diagnosis and treatment of medical conditions; cloud services (SaaS) and leasing of computer software for the diagnosis and treatment of conditions; development of measuring probes for biotechnological applications; hosting of computerized data digital files for the diagnosis and treatment of medical conditions, applications and information for the diagnosis and treatment of medical conditions; electronic data storage; data conversion of electronic information; programming of electronic control systems; testing of electronic data processing systems; conversion of images from physical to electronic media; design and development of electronic database software; creating electronically stored web pages for online services and the internet; platform as a service (PaaS) featuring software for the diagnosis and treatment of medical conditions; computer network configuration services; none of the above to include business process management nor web design and development for others nor information about health care providers nor software for tracking health care provider insurer compliance nor health care provider directory listing data | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Brighter AB (publ)
- Other trademarks owned by Brighter AB (publ)
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named BRIGHTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 18, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 28, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 28, 2023 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Feb 28, 2023 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Feb 28, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Feb 28, 2023 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Oct 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 20, 2021 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2021 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 25, 2021 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| May 25, 2021 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Dec 28, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 28, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 4, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 4, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 30, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 30, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 30, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 30, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 10, 2020 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 1, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 1, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 16, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2019 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 2, 2019 | NREV | NOTICE OF REVIVAL - MAILED | — |
| Jul 1, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 1, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 28, 2019 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 28, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 15, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 24, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 23, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 13, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 8, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 1, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |